Sign in

CIK 0001053369

  • Non-accelerated filer
  • Smaller reporting company

ELITE PHARMACEUTICALS INC /NV/

Sign in to watch
Ticker
ELTP
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
NJ
Entity type
Operating
EIN
223542636
Phone
+1 201-750-2646
Business address
165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
Former names
ELITE PHARMACEUTICALS INC /DE/
Open-market buys, last 90 days
$25,980
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$25,980. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Dash Barry H +$26K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2012-03-15 EPIC INVESTMENTS, LLC 10% owner Purchase · Series E Convertible Preferred Stock +125 $1,000.00 $125K 1,750
2012-03-14 NARINE JEENARINE Director Conversion +7,621,951 63,851,618
2012-03-14 NARINE JEENARINE Director Conversion · Series E Convertible Preferred Stock −187.5 $1,000.00 $188K 1,625
2012-03-14 NIGALAYE ASHOK G Chief Scientific Officer Conversion +7,621,951 63,851,618
2012-03-14 NIGALAYE ASHOK G Chief Scientific Officer Conversion · Series E Convertible Preferred Stock −187.5 $1,000.00 $188K 1,625
2012-03-14 POTTI RAM Director Conversion +7,621,951 63,443,669
2012-03-14 POTTI RAM Director Conversion · Series E Convertible Preferred Stock −187.5 $1,000.00 $188K 1,625
2012-03-14 EPIC PHARMA LLC 10% owner Conversion +7,621,951 63,443,669
2012-03-14 EPIC PHARMA LLC 10% owner Conversion · Series E Convertible Preferred Stock −187.5 $1,000.00 $188K 1,625
2012-03-14 EPIC INVESTMENTS, LLC 10% owner Conversion +7,621,951 63,443,669
2012-03-14 EPIC INVESTMENTS, LLC 10% owner Conversion · Series E Convertible Preferred Stock −187.5 $1,000.00 $188K 1,625
2012-02-21 POTTI RAM Director Conversion +52,845,528 55,821,718
2012-02-21 POTTI RAM Director Conversion · Series E Convertible Preferred Stock −1,300 $1,000.00 $1.3M 1,812.5
2012-02-21 NARINE JEENARINE Director Conversion +52,845,528 56,229,667
2012-02-21 NARINE JEENARINE Director Conversion · Series E Convertible Preferred Stock −1,300 $1,000.00 $1.3M 1,812.5
2012-02-21 NIGALAYE ASHOK G Chief Scientific Officer Conversion +52,845,528 56,229,667
2012-02-21 NIGALAYE ASHOK G Chief Scientific Officer Conversion · Series E Convertible Preferred Stock −1,300 $1,000.00 $1.3M 1,812.5
2012-02-21 EPIC PHARMA LLC 10% owner Conversion +52,845,528 55,821,718
2012-02-21 EPIC PHARMA LLC 10% owner Conversion · Series E Convertible Preferred Stock −1,300 $1,000.00 $1.3M 1,812.5
2012-02-21 EPIC INVESTMENTS, LLC 10% owner Conversion +52,845,528 55,821,718

Page 25 of 28 · 542 trades